Related Experiment Videos
[Molecular targeting therapy for leukemia by sphingolipid ceramide]
1Division of Clinical Laboratory Medicine/Hematology, Tottori University Faculty of Medicine, Yonago 683-8504.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 22, 2005
Summary
Ceramide, a lipid mediator, induces apoptosis in cancer cells. This mechanism offers a novel therapeutic strategy for treating chemoresistant hematological malignancies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Context:
- Ceramide is a crucial cell membrane component and intracellular lipid mediator.
- Its synthesis involves serine-palmitoyl CoA transferase, with species diversity arising from fatty acid chain length.
- Increased intracellular ceramide levels are linked to stress-induced apoptosis.
Purpose:
- To explore the role of ceramide in cellular stress response and apoptosis.
- To review recent advancements in hematological malignancy treatment.
- To propose ceramide-mediated apoptosis as a novel therapeutic target.
Summary:
- Ceramide acts as an intracellular mediator, transducing extracellular stress signals.
- Elevated ceramide levels activate pro-apoptotic pathways and inhibit survival signals, leading to programmed cell death.
- The study highlights ceramide's potential in targeting chemoresistant and refractory hematological malignancies.
Impact:
- Ceramide's role in apoptosis provides a new avenue for cancer therapy.
- This research suggests a potent molecular targeting strategy for difficult-to-treat blood cancers.
- Understanding ceramide's function can lead to innovative treatments for hematological malignancies.